S100A6 and cancer: In addition to meeting criteria for significance established for differentiating cancer associated serum proteins from control specimens (Table 1), S100A6 was regarded as a candidate for additional validation because of its increased expression in a variety of human cancers and its relatively small size (10.5 kDa).